scholarly article | Q13442814 |
P356 | DOI | 10.1212/01.WNL.0000044058.64647.7E |
P8608 | Fatcat ID | release_mvk4v3co5ze6ncwbi2ilo463t4 |
P698 | PubMed publication ID | 12601100 |
P2093 | author name string | Lane J | |
Sallee FR | |||
Raab D | |||
Gilbert DL | |||
Sethuraman G | |||
Dure L | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | randomized controlled trial | Q1436668 |
P304 | page(s) | 606-611 | |
P577 | publication date | 2003-02-01 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | Tic reduction with pergolide in a randomized controlled trial in children | |
P478 | volume | 60 |
Q24607941 | Contemporary assessment and pharmacotherapy of Tourette syndrome |
Q34817282 | Current controversies on the role of behavior therapy in Tourette syndrome |
Q24627768 | D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD |
Q34423658 | Emerging drugs in Tourette syndrome |
Q34796193 | Emerging treatments for Tourette's disorder. |
Q36873932 | Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders |
Q43131989 | Extrastriatal dopaminergic dysfunction in tourette syndrome |
Q28241323 | Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease |
Q38285461 | Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr |
Q34135110 | Neurobiological substrates of Tourette's disorder |
Q79219456 | New treatments for tic disorders |
Q34613057 | Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders |
Q55365792 | Pharmacotherapies to tics: a systematic review. |
Q34524415 | Practitioner Review: Treatments for Tourette syndrome in children and young people - a systematic review |
Q28972388 | Psychopharmacology of Tic Disorders |
Q37169898 | Randomized trial of behavior therapy for adults with Tourette syndrome |
Q33786160 | Recent advances in Tourette syndrome |
Q52569741 | Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome. |
Q24658223 | The management of tics |
Q36332445 | Tic disorders: from pathophysiology to treatment |
Q36592783 | Tic disorders: neural circuits, neurochemistry, and neuroimmunology |
Q81620916 | Tourette's Syndrome |
Q34565872 | Treatment of children and adolescents with tics and Tourette syndrome |
Q37579379 | Treatment of hyperkinetic movement disorders |
Q38215699 | Updates in medical and surgical therapies for Tourette syndrome |
Q80088577 | [Therapeutic management of tics in Tourette's syndrome] |